Summary -

Key Takeaways Explained for a Non-Medical Audience

– All participants achieved sustained nutritional ketosis (defined by elevated blood β-hydroxybutyrate) during the fasting period.

– Fasting led to significant weight loss, primarily from fat mass, with preserved lean body mass in most cases.

– Blood glucose levels decreased progressively during fasting, while insulin levels also dropped, reflecting improved insulin sensitivity.

– Serum triglycerides and total cholesterol levels decreased, along with improvements in HDL-to-triglyceride ratios.

– Inflammatory markers such as C-reactive protein declined in many participants, suggesting reduced systemic inflammation.

– Blood pressure significantly declined in hypertensive individuals, often reducing or eliminating the need for medications.

– No serious adverse events were reported, supporting the safety of long-term fasting when properly supervised.

– Uric acid levels temporarily rose during fasting but normalized post-refeeding without clinical issues in most individuals.

– Participants reported increased well-being and reduced hunger during fasting, attributed to ketone production and hormonal shifts.

– The fasting intervention was associated with reduced liver enzyme levels (ALT, AST), pointing to improved liver health.

– Improvements in lipid metabolism and insulin sensitivity were more pronounced in participants with metabolic syndrome.

– Long-term fasting altered hormonal profiles, including reduced leptin and improved cortisol regulation.

– The study confirmed that long-term fasting is both metabolically beneficial and safe across diverse age groups and health backgrounds.

– The beneficial effects were largely driven by the body’s shift from glucose to fat-derived ketones as a primary fuel source.

– Refeeding with whole, natural foods was essential for maintaining metabolic gains post-fasting.